Evidence map›Paper›PMID 29425462›Full record

ArticleAmerican journal of respiratory and critical care medicine2018

Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium Report.

Jason M Elinoff, Richa Agarwal, Christopher F Barnett, Raymond L Benza, Michael J Cuttica, Ahmed M Gharib, Michael P Gray, Paul M Hassoun, Anna R Hemnes, Marc Humbert and 11 more

Abstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. PFKFB3-mediated endothelial glycolysis promotes pulmonary hypertension.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  9. Diagnosis of pulmonary hypertension.The European respiratory journal · 2019
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Jason M Elinoff1 Clinical Center.
Richa Agarwal2 Division of Cardiovascular Disease, Department of Medicine, Allegheny General Hospital, Pittsburgh, Pennsylvania.
Christopher F Barnett3 MedStar Washington Hospital Center, Washington, DC.
Raymond L Benza2 Division of Cardiovascular Disease, Department of Medicine, Allegheny General Hospital, Pittsburgh, Pennsylvania.
Michael J Cuttica4 Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Ahmed M Gharib5 National Institute of Diabetes, Digestive, and Kidney Diseases, and.
Michael P Gray6 Pulmonary Hypertension Association, Silver Spring, Maryland.
Paul M Hassoun7 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
Anna R Hemnes8 Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Marc Humbert9 Service de Pneumologie, Hôpital Bicêtre (Assistance Publique-Hôpitaux de Paris), Institut National de la Santé et de la Recherche Médicale U999, University Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Todd M Kolb7 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
Tim Lahm10 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Indiana University, Indianapolis, Indiana.
Jane A Leopold12 Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Stephen C Mathai7 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
Vallerie V McLaughlin13 Division of Cardiology, Department of Medicine, University of Michigan, Ann Arbor, Michigan.
Ioana R Preston14 Department of Medicine, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts.
Erika B Rosenzweig15 Department of Medicine, Columbia School of Medicine, New York, New York.
Oksana A Shlobin16 Pulmonary Vascular Disease Program, Inova Fairfax Hospital, Falls Church, Virginia.
Virginia D Steen17 Rheumatology Division, Department of Medicine, Georgetown University, Washington, DC; and.
Roham T Zamanian18 Stanford University, Department of Medicine, Stanford, California.
Michael A Solomon1 Clinical Center.

Funding

Advanced Non Invasive Vascular Imaging MethodsZIADK075083 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI GHARIB, AHMED · 2013 to 2025
$34.7M
Intergrated Endothelial Phenotyping to Redefine Pulmonary HypertensionU01HL125215 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LEOPOLD, JANE A, WAXMAN, AARON B · 2014 to 2018
$1.7M
Hypoxia-mediated protective estrogen receptor signaling in pulmonary hypertensionI01BX002042 · VA · VA EASTERN COLORADO HEALTH CARE SYSTEM · PI Tim Lahm · 2014 to 2026
–
BLRD VA I01 BX002042NHLBI NIH HHS U01 HL125215
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Practice Guidelines as TopicAdultAgedAged, 80 and overAntihypertensive AgentsCongresses as TopicFemaleGenetic TestingGenetic VariationHumansHypertension, PulmonaryMaleMiddle AgedNational Institutes of Health (U.S.)PhenotypeUnited StatesAntihypertensive Agents

Identifiers

PMID29425462
PMCPMC6058980

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.